List of insiders holdings for NextCure Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 2024-03-08 16:34:44 | 1,268,013 0 | 1,268,013 | Form 13D |
| 2 | Xu Stella Quan Venture Fund II L.P. Director 10% Owner | 2019-05-08 20:04:37 | 0 978,570 | 978,570 | Form 3 |
| 3 | CANAAN X L.P. Canaan Partners X LLC 10% Owner | 2021-02-03 14:52:58 | 838,442 0 | 838,442 | Form 13G |
| 4 | Simcere Zaiming Inc. Jiangsu Simcere Zaiming Pharmaceutical Co. Ltd. Hainan Simcere Zaiming Pharmaceutical Co. Ltd. Simcere Pharmaceutical Group Ltd Ren Jinsheng Tang Renhong 10% Owner | 2025-09-29 16:00:11 | 0 338,636 | 338,636 | Form 3/A |
| 5 | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 2026-03-05 06:06:07 | 222,654 0 | 222,654 | Form 13D |
| 6 | Alexandria Venture Investments LLC 10% Owner | 2019-05-13 19:49:34 | 197,993 0 | 197,993 | Form 4 |
| 7 | Langermann Sol Chief Scientific Officer | 2025-02-03 18:22:38 | 117,375 0 | 117,375 | Form 4 |
| 8 | Myint Han Chief Medical Officer | 2024-04-02 16:43:17 | 93,900 0 | 93,900 | Form 4 |
| 9 | Heller Kevin N. Chief Medical Officer | 2020-07-16 16:51:15 | 87,130 0 | 87,130 | Form 4 |
| 10 | Bingham James B. Chief Development Officer | 2020-03-03 16:38:20 | 78,200 0 | 78,200 | Form 4 |
| 11 | Liu Linda SVP, Research | 2022-02-02 16:22:00 | 65,600 0 | 65,600 | Form 4 |
| 12 | Richman Michael President & CEO | 2026-02-03 16:07:18 | 38,190 0 | 38,190 | Form 4 |
| 13 | KABAKOFF DAVID S Director | 2025-06-24 16:31:00 | 28,050 0 | 28,050 | Form 4 |
| 14 | SHANNON TIMOTHY M Director | 2019-06-17 20:21:08 | 22,000 0 | 22,000 | Form 4 |
| 15 | Borgman Anne Elizabeth Director | 2025-06-24 16:30:49 | 18,700 0 | 18,700 | Form 4 |
| 16 | Houston John G Director | 2025-06-24 16:31:30 | 18,700 0 | 18,700 | Form 4 |
| 17 | Jones Elaine V Director | 2025-06-24 16:31:17 | 18,700 0 | 18,700 | Form 4 |
| 18 | Webster Stephen W Director | 2025-06-24 16:30:40 | 18,700 0 | 18,700 | Form 4 |
| 19 | Feigal Ellen Director | 2025-06-24 16:30:32 | 18,700 0 | 18,700 | Form 4 |
| 20 | Cobourn Steven P. Chief Financial Officer | 2026-02-03 16:07:17 | 14,670 0 | 14,670 | Form 4 |
| 21 | Guha Udayan Chief Medical Officer | 2026-02-03 16:07:20 | 14,670 0 | 14,670 | Form 4 |
| 22 | Mayer Timothy Chief Operating Officer | 2026-02-03 16:07:19 | 14,670 0 | 14,670 | Form 4 |
| 23 | Morrison Briggs Director | 2020-06-15 17:45:23 | 14,250 0 | 14,250 | Form 4 |
| 24 | Li Judith Director | 2020-06-15 17:43:42 | 14,250 0 | 14,250 | Form 4 |
| 25 | Nicholson Garry A Director | 2023-06-23 16:31:09 | 14,250 0 | 14,250 | Form 4 |
| 26 | Khuong Chau Quang Director | 2023-06-23 16:31:02 | 14,250 0 | 14,250 | Form 4 |
| 27 | Xu Stella Director | 2021-06-28 18:16:25 | 14,250 0 | 14,250 | Form 4 |
| 28 | Kundu Sourav Sr VP, Dev. & Mfg. | 2026-02-03 16:07:20 | 8,270 0 | 8,270 | Form 4 |
| 29 | Shaw Kevin G. Sr VP, General Counsel | 2026-02-03 16:07:22 | 8,270 0 | 8,270 | Form 4 |